Clinical trial
A Phase I Dose Escalation Study to Assess the Pharmacokinetics (PK) of FDL169 in Healthy Female Volunteers
NCT02680418 is registered in ClinicalTrials.gov with Flatley Discovery Lab LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Dose Escalation Study to Assess the Pharmacokinetics (PK) of FDL169 in Healthy Female Volunteers
- Lead sponsor
- Flatley Discovery Lab LLC
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- February 29, 2016
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.